Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Burjeel HoldingsADX:BURJEEL -3.60%79 EBITDA Margin % is 15.45% as of Mar. 2026, which is 26% below its 10-year median of 20.81. GuruFocus rates ADX:BURJEEL with a GF Score™ of 79/100 and a GF Value™ of د.إ2.54 (Significantly Undervalued). The stock has 6 warning signs investors should review. Among 664 Healthcare Providers & Services companies, Burjeel Holdings ranks better than 75.45% on this metric.
EBITDA Margin % is calculated as EBITDA divided by its Revenue. Burjeel Holdings's EBITDA for the
three
months ended in Mar. 2026 was د.إ201 Mil. Burjeel Holdings's Revenue for the
three
months ended in Mar. 2026 was د.إ1,302 Mil. Therefore, Burjeel Holdings's EBITDA margin for the quarter that ended in Mar. 2026 was 15.45%.
EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.
Burjeel Holdings EBITDA Margin % Related Terms
Burjeel Holdings EBITDA Margin % Historical Data
* Premium members only.
The historical data trend for Burjeel Holdings's EBITDA Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
ADX:BURJEEL vs HCA, THC, DVA: EBITDA Margin % Comparison
For the Medical Care Facilities subindustry, Burjeel Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Burjeel Holdings EBITDA Margin % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Burjeel Holdings's EBITDA Margin % distribution charts can be found below:
* The bar in red indicates where Burjeel Holdings's EBITDA Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Burjeel Holdings (ADX:BURJEEL) has a EBITDA Margin % of 15.45% as of Mar. 2026. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Burjeel Holdings and its competitors. This is 26% below median its historical median of 20.81. Over the past decade, Burjeel Holdings' EBITDA Margin % has ranged from 18.46 to 25.12. According to the industry distribution chart, Burjeel Holdings ranks #163 out of 664 companies in the Healthcare Providers & Services industry, placing it in the top 24.5%.
Is Burjeel Holdings' EBITDA Margin % too high?
Burjeel Holdings' current EBITDA Margin % of 15.45% is 26% below median its 10-year median of 20.81. Over the past 10 years, this metric has ranged from a low of 18.46 to a high of 25.12. The Healthcare Providers & Services industry median EBITDA Margin % is 10.24. Burjeel Holdings' value of 15.45% is 51% above this industry median. Based on the distribution chart, Burjeel Holdings ranks #163 out of 664 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, Burjeel Holdings has a GF Score™ of 79/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Burjeel Holdings' EBITDA Margin % compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Burjeel Holdings ranks #163 out of 664 companies for EBITDA Margin %. This places Burjeel Holdings in the top 25% of its industry — outperforming the majority of peers. The industry median EBITDA Margin % is 10.24. Burjeel Holdings' value of 15.45% is 51% above this benchmark. Historically, Burjeel Holdings' own EBITDA Margin % has ranged from 18.46 to 25.12 over the past decade. While the company's 10-year median is 20.81 vs. the industry median of 10.24, Burjeel Holdings has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Healthcare Providers & Services company?
The median EBITDA Margin % among Healthcare Providers & Services companies is 10.24, based on 664 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Burjeel Holdings's current EBITDA Margin % of 15.45% is 51% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on Burjeel Holdings and its competitors. For the Healthcare Providers & Services industry, the median EBITDA Margin % is 10.24 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Burjeel Holdings's current EBITDA Margin % is 15.45%, which is 26% below median its own 10-year median of 20.81. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Burjeel Holdings stock overvalued right now?
Based on GuruFocus' analysis, Burjeel Holdings (ADX:BURJEEL) is currently considered Significantly Undervalued. The stock's GF Value™ is د.إ2.54, compared to a current price of د.إ1.07 — trading 57.9% below its estimated fair value. The current EBITDA Margin % is 15.45%, which is 26% below median its 10-year median of 20.81 and 51% above the Healthcare Providers & Services industry median of 10.24. Burjeel Holdings' overall GF Score™ is 79/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For Burjeel Holdings (ADX:BURJEEL), the current EBITDA Margin % is 15.45% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Burjeel Holdings (ADX:BURJEEL) Overvalued in 2026?
Based on GuruFocus' analysis, Burjeel Holdings stock appears to be undervalued.
The current stock price of د.إ1.07 is trading 57.9% below its estimated GF Value™ of د.إ2.54.
GuruFocus considers Burjeel Holdings to be Significantly Undervalued.
Key valuation signals for ADX:BURJEEL:
EBITDA Margin %: 15.45% (26% below median its 10-year median of 20.81)
GF Value™: د.إ2.54 vs. price of د.إ1.07 (57.9% below fair value)
Industry Position: 51% above the Healthcare Providers & Services median (#163 of 664)
No single metric tells the full story. See the ADX:BURJEEL stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Burjeel Holdings PLC is a healthcare service provider. Along with its subsidiaries, it provides multi-specialty hospitals, medical, surgical and dental services, and the sale of pharmaceutical goods and medical equipment. The group's reportable segments are Hospitals, Medical Centre, Pharmacies, and Others. Maximum revenue for the group is derived from the Hospitals segment, which includes entities that provide inpatient, day-care services, and outpatient services to patients to diagnosis the disease and offer medical and surgical treatment as part of in-patient services. Geographically it derives maximum revenue from its customers in the United Arab Emirates, followed by the Sultanate of Oman and the Kingdom of Saudi Arabia.
79GF Score
Get the complete analysis for ADX:BURJEEL
EBITDA Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ADX:BURJEEL has been successfully added to your 
